Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0038389992
Mon, 20.05.2024
Edison Investment Research Limited
London, UK, 20 May 2024
Edison issues review on BB Biotech (BION): A recovering sector with a healthy prognosis
BB Biotech (BION) offers investors exposure to the innovative, rapidly expanding biotech sector. It is the largest biotech investor among its investment company peers, focused on high-quality biotech assets that target substantial [ … ]
Thu, 21.03.2024
BB BIOTECH AG
Media release of March 21, 2024
Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share
All proposals of BB Biotech AG's Board of Directors were approved by BB Biotech AG's shareholders at its Annual General Meeting held today.
Shareholders voted in favor of the proposal to pay out a divi [ … ]
Fri, 16.02.2024
BB BIOTECH AG
Ad hoc announcement pursuant to Art. 53 LR
February 16, 2024
Annual report of BB Biotech AG as at December 31, 2023
BB Biotech AG publishes its 2023 annual report
BB Biotech AG published its annual report for fiscal year 2023 today. Besides the audited consolidated financial statements, the annual report contains detailed information on the bi [ … ]
Wed, 14.02.2024
BB BIOTECH AG
Release as at February 14, 2024Investor interest returns – dividend yield remains high for 2024
After a difficult 2023 stock market year, above all due to higher interest rates, the capital markets are now once again looking at biotech companies with interest. The prospect of falling interest rates has led to a rethink. While the majority of inves [ … ]
Fri, 19.01.2024
BB BIOTECH AG
Ad hoc announcement pursuant to Art. 53 LR
January 19, 2024
BB Biotech AG publishes financial results for 2023 and changes to the Board of Directors
In accordance with regulations on ad hoc publicity, BB Biotech AG (ISIN CH0038389992) is releasing the following information:
Results for the financial year 2023
Based on its preliminary unaudited [ … ]
Fri, 19.01.2024
BB BIOTECH AG
Media release as at January 19, 2024
Portfolio of BB Biotech AG as at December 31, 2023
End of year biotech equity market rally – M&A and end of rate hike cycle
In 2023, global equity performed better than anticipated by many. The US central bank moderated and then paused interest rate hikes. These developments resulted in a year-end bond ma [ … ]
Fri, 20.10.2023
BB BIOTECH AG
Ad hoc announcement pursuant to Art. 53 LR
October 20, 2023
BB Biotech AG publishes its interim report
BB Biotech AG (ISIN CH0038389992) today published its interim report as at September 30, 2023, which covers the results of its business activities for the first nine months of 2023.
Based on the consolidated accounts of BB Biotech AG, net loss [ … ]
Fri, 20.10.2023
BB BIOTECH AG
Media release as at October 20, 2023
Interim report of BB Biotech AG as at September 30, 2023
Biotech equity markets in flux: the impact of rising bond yields and shifting healthcare policies
Expectations that the US central bank would soon reverse its monetary policy stance proved to be premature. The rise in bond yields weighed heavily on biot [ … ]
Fri, 21.07.2023
BB BIOTECH AG
Ad hoc announcement pursuant to Art. 53 LR
July 21, 2023
BB Biotech AG publishes its interim report
BB Biotech AG (ISIN CH0038389992) today published its interim report as at June 30, 2023, which covers the results of its business activities for the first six months of 2023.
Based on the consolidated accounts of BB Biotech AG, net loss for the [ … ]
Fri, 21.07.2023
BB BIOTECH AG
Media release as at July 21, 2023
Interim report of BB Biotech AG as at June 30, 2023
Sector rotation and fund outflows weigh on biotech stocks, but positive developments allow fund raising to strengthen industry
The first half of 2023 has been disappointing for biotech investors. A massive rotation has put biotech stocks under pressure. Whereas [ … ]